title: Tumor-associated macrophages: functional diversity, clinical significance, and open questions.
abstract: Inflammation is now a well-recognized hallmark of cancer progression. Tumor-associated macrophages (TAMs) are one of the major inflammatory cells that infiltrate murine and human tumors. While epidemiological studies indicate a clear correlation between TAM density and poor prognosis in a number of human cancers, transgenic studies and transcriptome profiling of TAMs in mice have established their crucial role in cancer progression. In fact, TAMs affect diverse aspects of cancer progression including tumor cell growth and survival, invasion, metastasis, angiogenesis, inflammation, and immunoregulation. New evidences have extended the repertoire of these cells to other tumor promoting activities like interactions with cancer stem cells, response to chemotherapy, and tumor relapse. These findings have triggered efforts to target TAMs and their associated molecules to modulate tumor progression. In particular, "re-education" to activate their anti-tumor potential or elimination of tumor promoting TAMs are strategies undergoing preclinical and clinical evaluation. Proof-of-principle studies indicate that TAM-centered therapeutic strategies may contribute to cancer therapy.
authors: Singapore Immunology Network SIgN, Agency for Science, Technology & Research A*STAR, #04-01 Immunos, 8A Biomedical Grove, Singapore, 138648, Singapore. subhra_biswas@immunol.a-star.edu.sg
authors: Subhra K
authors: SK
authors: Biswas
authors: Paola
authors: P
authors: Allavena
authors: Alberto
authors: A
authors: Mantovani
mesh_terms: D000818:Animals; D016207:Cytokines / Q000276:immunology; D018450:Disease Progression; D014644:Genetic Variation / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000276:immunology*; D008262:Macrophage Activation / Q000276:immunology; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology*
chemical_list: D016207:Cytokines
references: Immunity. 2013 Jan 24;38(1):79-91
references: 23273845
references: Cancer Res. 2009 Jun 1;69(11):4800-9
references: 19458073
references: Cancer Cell. 2008 Oct 7;14(4):299-311
references: 18835032
references: Eur J Immunol. 2011 Aug;41(8):2155-64
references: 21710478
references: Blood. 2008 Jun 15;111(12):5457-66
references: 18375791
references: Cancer Cell. 2005 Sep;8(3):211-26
references: 16169466
references: Cancer Cell. 2012 Apr 17;21(4):488-503
references: 22516258
references: Cell. 2004 Aug 6;118(3):285-96
references: 15294155
references: Am J Pathol. 1997 May;150(5):1723-34
references: 9137096
references: Cancer Cell. 2011 Apr 12;19(4):512-26
references: 21481792
references: Science. 2011 Mar 25;331(6024):1612-6
references: 21436454
references: Cancer Res. 2006 Dec 1;66(23):11432-40
references: 17145890
references: J Exp Med. 2001 Mar 19;193(6):727-40
references: 11257139
references: J Immunol. 2000 Jan 15;164(2):733-8
references: 10623817
references: Neoplasia. 2009 Nov;11(11):1235-42
references: 19881959
references: J Clin Invest. 2007 May;117(5):1155-66
references: 17476345
references: Cell. 2010 Apr 2;141(1):39-51
references: 20371344
references: Cell. 2011 Mar 4;144(5):646-74
references: 21376230
references: Am J Pathol. 2009 Mar;174(3):1048-64
references: 19218341
references: Nature. 2008 Dec 11;456(7223):814-8
references: 18997773
references: Cancer Res. 2006 Apr 15;66(8):4349-56
references: 16618760
references: Cancer Cell. 2009 Aug 4;16(2):91-102
references: 19647220
references: Lancet. 2012 Apr 28;379(9826):1602-12
references: 22440946
references: J Exp Med. 2012 Jan 16;209(1):139-55
references: 22231304
references: J Clin Invest. 2007 Jan;117(1):175-84
references: 17200717
references: Am J Pathol. 2002 Sep;161(3):947-56
references: 12213723
references: Proc Natl Acad Sci U S A. 2010 May 4;107(18):8363-8
references: 20404138
references: Nature. 2012 Nov 8;491(7423):254-8
references: 23034650
references: Immunity. 2009 Sep 18;31(3):502-12
references: 19733097
references: Cell. 2006 Feb 24;124(4):823-35
references: 16497591
references: Science. 2012 Apr 6;336(6077):86-90
references: 22442384
references: J Natl Cancer Inst. 1994 Jan 19;86(2):120-6
references: 8271294
references: J Exp Med. 1992 Jul 1;176(1):287-92
references: 1613462
references: Biochim Biophys Acta. 1986 Aug 5;865(1):59-67
references: 2425851
references: Cancer Res. 2010 Jul 1;70(13):5270-80
references: 20530679
references: Nature. 2008 Jun 5;453(7196):807-11
references: 18432192
references: J Clin Invest. 2007 Jan;117(1):195-205
references: 17200719
references: Cancer Cell. 2012 Mar 20;21(3):309-22
references: 22439926
references: J Exp Med. 2003 Nov 3;198(9):1391-402
references: 14597738
references: Cancer Res. 2005 Nov 15;65(22):10578-84
references: 16288051
references: Cancer Cell. 2013 Feb 11;23(2):249-62
references: 23410977
references: Nat Rev Immunol. 2008 Dec;8(12):958-69
references: 19029990
references: Cell. 2010 Sep 3;142(5):699-713
references: 20813259
references: J Immunol. 2005 Jul 15;175(2):1197-205
references: 16002723
references: Blood. 2012 Oct 18;120(16):3280-7
references: 22948049
references: Cancer Res. 2010 Jul 15;70(14):5728-39
references: 20570887
references: Nat Rev Immunol. 2005 Oct;5(10):749-59
references: 16175180
references: Curr Opin Immunol. 2006 Feb;18(1):39-48
references: 16337366
references: Cell. 2006 Jan 27;124(2):263-6
references: 16439202
references: J Clin Invest. 2011 May;121(5):1969-73
references: 21490397
references: Cancer Cell. 2010 Feb 17;17(2):121-34
references: 20138013
references: Cell. 2005 Jul 1;121(7):977-90
references: 15989949
references: Blood. 2007 Jun 15;109(12):5276-85
references: 17327411
references: Trends Immunol. 2004 Dec;25(12):677-86
references: 15530839
references: Cancer Discov. 2011 Jun;1(1):54-67
references: 22039576
references: Science. 2011 Jun 10;332(6035):1284-8
references: 21566158
references: J Pathol. 2002 Mar;196(3):254-65
references: 11857487
references: Immunol Rev. 2008 Apr;222:155-61
references: 18364000
references: Cancer Res. 2013 Feb 1;73(3):1128-41
references: 23221383
references: Clin Cancer Res. 2013 Apr 1;19(7):1670-80
references: 23363815
references: PLoS One. 2013;8(2):e56045
references: 23409120
references: Cell Stem Cell. 2012 Dec 7;11(6):730-2
references: 23217416
references: Trends Immunol. 2013 Feb;34(2):81-9
references: 23000011
references: Cancer Cell. 2011 Apr 12;19(4):541-55
references: 21481794
references: Nat Med. 2013 Jan;19(1):57-64
references: 23202296
references: Annu Rev Immunol. 1984;2:283-318
references: 6100475
references: J Immunol. 2010 Jul 1;185(1):605-14
references: 20498354
references: J Immunol. 2006 Nov 15;177(10):7303-11
references: 17082649
references: Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2491-6
references: 22308361
references: Science. 2010 Nov 5;330(6005):841-5
references: 20966214
references: Genes Dev. 2011 Dec 1;25(23):2465-79
references: 22156207
references: Methods Mol Biol. 2007;361:227-38
references: 17172715
references: J Immunol. 2007 Feb 1;178(3):1357-62
references: 17237382
references: Trends Immunol. 2012 Mar;33(3):119-26
references: 22277903
references: Nat Rev Immunol. 2011 Oct 14;11(11):723-37
references: 21997792
references: Genes Dev. 2010 Feb 1;24(3):241-55
references: 20080943
references: Lancet. 2012 Apr 28;379(9826):1591-601
references: 22440947
references: J Exp Med. 2009 Jun 8;206(6):1327-37
references: 19451266
references: Cancer Res. 2013 Jan 15;73(2):490-5
references: 23172310
references: Clin Cancer Res. 2000 Aug;6(8):3282-9
references: 10955814
references: Int J Cancer. 2009 Oct 1;125(7):1640-8
references: 19569243
references: Trends Immunol. 2002 Nov;23(11):549-55
references: 12401408
references: Cancer Res. 2010 Jan 1;70(1):68-77
references: 20028852
references: Cancer Cell. 2011 Jan 18;19(1):31-44
references: 21215706
references: Nature. 2008 Jul 24;454(7203):436-44
references: 18650914
references: J Immunol. 1990 Jun 15;144(12):4878-82
references: 2161881
references: Cancer Res. 2006 Dec 1;66(23):11238-46
references: 17114237
references: Lancet. 2001 Feb 17;357(9255):539-45
references: 11229684
references: J Exp Med. 1994 Dec 1;180(6):2365-70
references: 7525853
references: Int Immunopharmacol. 2011 Jul;11(7):862-72
references: 21251905
references: J Clin Invest. 2009 Oct;119(10):3011-23
references: 19741298
references: Cancer Cell. 2010 Aug 9;18(2):160-70
references: 20708157
references: Eur J Immunol. 2012 Apr;42(4):957-74
references: 22531920
references: PLoS One. 2012;7(12):e50946
references: 23284651
references: Cancer Res. 2010 May 1;70(9):3526-36
references: 20406969
references: Cell Stem Cell. 2012 Dec 7;11(6):812-24
references: 23168163
references: Blood. 2006 Mar 1;107(5):2112-22
references: 16269622
references: Lancet. 2008 Mar 1;371(9614):771-83
references: 18275997
references: Trends Immunol. 2009 Oct;30(10):475-87
references: 19781994
references: Cancer Res. 2011 Feb 15;71(4):1263-71
references: 21303976
references: Nature. 2002 Dec 19-26;420(6917):860-7
references: 12490959
references: Cancer Cell. 2005 Mar;7(3):211-7
references: 15766659
references: J Immunol. 2006 Apr 15;176(8):5023-32
references: 16585599
references: Nature. 2011 Jun 08;475(7355):222-5
references: 21654748
references: Clin Cancer Res. 2009 Jul 1;15(13):4391-400
references: 19549768
references: Immunity. 2013 Feb 21;38(2):296-308
references: 23333075
references: J Immunol. 2000 Jun 15;164(12):6166-73
references: 10843666
references: Cancer Res. 2005 Apr 15;65(8):3437-46
references: 15833879
references: Blood. 2012 Jan 5;119(1):227-37
references: 22058116
references: BMC Immunol. 2011 Aug 04;12:43
references: 21813021
references: BJU Int. 2011 Jun;107(12):1918-22
references: 21044246
references: Lancet. 2012 Apr 28;379(9826):1569-71
references: 22440945
references: J Immunol. 2001 Jun 1;166(11):6861-8
references: 11359846
references: J Clin Invest. 2010 Mar;120(3):694-705
references: 20179352
references: Cell Metab. 2012 Apr 4;15(4):432-7
references: 22482726
references: Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12425-30
references: 21746895
references: J Clin Invest. 2012 Mar;122(3):787-95
references: 22378047
references: Eur J Immunol. 2009 Aug;39(8):2126-35
references: 19609975
references: Nature. 2011 Dec 07;481(7379):85-9
references: 22158103
references: BMC Cancer. 2012 Jul 23;12:306
references: 22824040
references: Blood. 2010 Aug 5;116(5):829-40
references: 20404134
references: J Exp Med. 2012 Sep 24;209(10):1869-82
references: 22927549
references: J Immunol. 2000 Jan 15;164(2):762-7
references: 10623821
references: Br J Cancer. 2006 Aug 7;95(3):272-81
references: 16832418
references: Nat Immunol. 2010 Oct;11(10):889-96
references: 20856220
references: Science. 2007 Aug 3;317(5838):666-70
references: 17673663
references: Nat Rev Immunol. 2005 Dec;5(12):953-64
references: 16322748
references: BMC Immunol. 2002 Jul 04;3:7
references: 12098359
references: Blood. 2009 Jul 23;114(4):901-14
references: 19383967
references: Science. 2008 May 9;320(5877):807-11
references: 18467591
references: J Immunol. 1992 Feb 15;148(4):1280-5
references: 1737940
references: Cancer Res. 2000 Oct 15;60(20):5857-61
references: 11059783
references: Eur J Immunol. 2012 Jan;42(1):89-100
references: 22009685
references: N Engl J Med. 2010 Mar 11;362(10):875-85
references: 20220182
references: J Exp Med. 2008 Jun 9;205(6):1261-8
references: 18490490
references: J Immunol. 2008 Feb 15;180(4):2011-7
references: 18250403
references: Curr Opin Immunol. 2012 Apr;24(2):207-12
references: 22236695